GLP Watchdog

GLP-1 Providers in Massachusetts (2026)

174 sellers list Massachusetts as a shipping state. The lowest regular price among them is $79/mo, and Massachusetts Medicaid dropped weight-loss coverage in July 2026.

174 sellersfrom $79/moMedicaid dropped weight-loss coverage in July 2026

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

174 of the 238 sellers that publish a state list include Massachusetts, the 38th-most of the 50 states and DC. 128 of them ship to all 50 states, and 1 serves 15 states or fewer. Across the 143 with a regular monthly price, the middle figure is $175/mo.

Massachusetts Medicaid stopped paying for GLP-1 drugs prescribed only for weight loss in July 2026. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Featured Partners · Massachusetts

Featured GLP-1 providers serving Massachusetts

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

  1. Top pick
    9.0
    CoreAge Rx

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  2. 9.4
    Trimi Health

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 9.0
    bmiMD

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. 6.7
    RxSpan MD

    Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →
  5. 8.4
    Strut Health

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. 8.4
    Enhance MD

    Compounded from

    $112/mo

    Save $1,237/mo vs Wegovy
    Get started →
See all 174 GLP-1 providers serving Massachusetts ↓

Who Ships GLP-1s to Massachusetts

  1. Embody $79/mo
  2. Lean Meds $79/mo
  3. NextMeds $79/mo

Lowest regular prices for Massachusetts: Embody at $79/mo, Lean Meds at $79/mo and NextMeds at $79/mo.

Smaller-footprint sellers that include Massachusetts: OlleveCare (13 states).

11 sellers that list 30 or more states leave Massachusetts off, among them Rebody Health, Curex, DoctorAdam, Gatlan and Mixx Health & Wellness.

Seller counts next door: Connecticut 181, New Hampshire 179, New York 193, Rhode Island 169 and Vermont 177.

Connecticut (181)New Hampshire (179)New York (193)Rhode Island (169)Vermont (177)

Browse by medication

Massachusetts Semaglutide Providers →
156 sellers, from $79/mo
Massachusetts Tirzepatide Providers →
140 sellers, from $97/mo

Massachusetts Medicaid and GLP-1 Coverage

Massachusetts Medicaid stopped paying for GLP-1 drugs prescribed only for weight loss in July 2026. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

  • Wegovy to cut heart attack and stroke risk: covered with prior authorization (a BMI of at least 27; established cardiovascular disease; major cardiac events risk reduction).
  • Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2, F3).
  • Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a BMI of at least 30).
  • Weight-loss GLP-1s for adolescents from age 12: covered with prior authorization.
Prior authorization
Pharmacy benefit managerConduent (MHDL platform)
Enrollmentabout 2,000,000 people (May 2026)
If the request is denied
Time to file an appeal30 days
Appeals officeMassHealth Office of Medicaid Board of Hearings (BOH)
Rule that governs it130 CMR 610.015
“In accordance with anticipated forthcoming changes to MassHealth regulations, 130 CMR 406.413(B), MassHealth will no longer cover drugs used for the treatment of obesity or overweight. Effective July 1, 2026, the drugs listed below in Table 1 will no longer be covered for MassHealth members, when used for weight loss.”
MassHealth Pharmacy Facts Number 271, March 12, 2026

In 2025, Massachusetts Medicaid paid for at least 399,014 GLP-1 prescriptions, including at least 41,461 for Ozempic, at least 9,167 for Wegovy, at least 61,274 for Mounjaro and at least 208,115 for Zepbound, about $404.5 million before manufacturer rebates. Drugs labeled for weight loss made up 56% of that spending.

Medicaid rules checked August 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Massachusetts

Massachusetts has 845 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 11.84 per 100,000 residents (6th of 51). By specialty: 251 bariatric, 594 endocrinology and 17 obesity medicine. About 27% of adults here had obesity in 2024 (CDC), the 47th-highest rate of the 50 states and DC. Measured against the median state, Massachusetts has 0.57 times as much adult obesity per specialist practice.

Every GLP-1 Provider Serving Massachusetts

9.3/ 10
Verified partner

Embody

Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy

★★★★★4.7/5

Editorial score · methodology

$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →
9.0/ 10
Verified partner

Live Vital

Best for: semaglutide at $99/month, 48% below the typical price

★★★★★4.5/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideRetatrutideBPC-157
Get StartedRead full Live Vital review →
8.7/ 10
Verified partner

Gala

Best for: moving between compounded and brand without changing seller

★★★★☆4.4/5

Editorial score · methodology

$129/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Gala review →
8.6/ 10
Verified partner

Found

Best for: tirzepatide at $169/month, 37% below the typical price

★★★★☆4.3/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →
7.3/ 10
Verified partner

Willow

Best for: seeing what it charges before you answer any medical questions

★★★★☆3.7/5

Editorial score · methodology

$299/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Willow review →
Open the full A–Z list of 174 providers in Massachusetts

312 more sellers publish no state list

Their signup form tells you whether they ship to Massachusetts.

5.7/ 10
Verified partner

HumeCare+

Best for: an oral route if you will not self-inject

★★★☆☆2.9/5

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full HumeCare+ review →
6.5/ 10
Verified partner

Sesame Care

Best for: oral orforglipron alongside the injectables

★★★☆☆3.3/5

Editorial score · methodology

$59/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
8.4/ 10
Verified partner

Collective

Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top

★★★★☆4.2/5

Editorial score · methodology

$59/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
7.7/ 10
Verified partner

HealthRX

Best for: compounded semaglutide at $133/month

★★★★☆3.9/5

Editorial score · methodology

$133/mo
SemaglutideTirzepatide
Get StartedRead full HealthRX review →
7.3/ 10
Verified partner

RNK Health

Best for: an oral route if you will not self-inject

★★★★☆3.7/5

Editorial score · methodology

$197/mo
CompoundedSemaglutideTirzepatideNAD+Sermorelin
Get StartedRead full RNK Health review →
5.9/ 10
Verified partner

SkinnyRx

Best for: starting below a standard dose, with microdose tiers

★★★☆☆3/5

Editorial score · methodology

$149.25/mo
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full SkinnyRx review →

Largest Cities in Massachusetts

BostonWorcesterSpringfieldCambridge

Frequently Asked Questions

The lowest regular prices from sellers that ship to Massachusetts are $79/mo at Embody, $79/mo at Lean Meds and $79/mo at NextMeds. Half of the 143 priced sellers charge $175/mo or less.
Massachusetts Medicaid stopped paying for GLP-1 drugs prescribed only for weight loss in July 2026. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization. Wegovy to cut heart attack and stroke risk: covered with prior authorization (a BMI of at least 27; established cardiovascular disease; major cardiac events risk reduction). Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2, F3). Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a BMI of at least 30).
Pharmacy claims run through Conduent (MHDL platform).
A denial can be appealed within 30 days through the MassHealth Office of Medicaid Board of Hearings (BOH).
174, counting sellers whose published state list includes Massachusetts. 128 of those list every state, and OlleveCare is among the few that serve 15 states or fewer. For comparison, Connecticut has 181, New Hampshire has 179 and New York has 193.
Rebody Health (47 states), Curex (45 states), DoctorAdam (44 states), Gatlan (44 states), Mixx Health & Wellness (44 states) and EOS Health (40 states) publish long state lists that leave Massachusetts out.
In 2025, Massachusetts Medicaid paid for at least 399,014 GLP-1 prescriptions, including at least 41,461 for Ozempic, at least 9,167 for Wegovy, at least 61,274 for Mounjaro and at least 208,115 for Zepbound, about $404.5 million before manufacturer rebates. Drugs labeled for weight loss made up 56% of that spending.
Massachusetts has 845 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 11.84 per 100,000 residents (6th of 51). By specialty: 251 bariatric, 594 endocrinology and 17 obesity medicine. About 27% of adults here had obesity in 2024 (CDC), the 47th-highest rate of the 50 states and DC. Measured against the median state, Massachusetts has 0.57 times as much adult obesity per specialist practice.

Rankings: semaglutide providers · tirzepatide providers · clinical-trial results · GLP-1 pipeline

Glossary

The words sellers use, defined. Tap any term.

Put every provider side by sideRun the savings math